Stephacidin A and B: Two Structurally Novel, Selective Inhibitors of the Testosterone-Dependent Prostate LNCaP Cells

Citations Over TimeTop 17% of 2002 papers

Abstract

Two novel antitumor alkaloids, Stephacidin A and B, were isolated from the solid fermentation of Aspergillus ochraceus WC76466. Both alkaloids exhibit in vitro cytotoxicity against a number of human tumor cell lines; however, stephacidin B demonstrated more potent and selective antitumor activities, especially against prostate testeosterone-dependent LNCaP cells with IC50 value of 60 nM. The structures of stephacidin A and B were established on the basis of the NMR data and X-ray crystallography. With 15 rings and 9 chiral centers, stephacidin B represents one of the most structurally complex and novel alkaloids occurring in nature.

Related Papers

• → Identification of androgen-regulated genes in human prostate(2012)58 cited
• → Design, synthesis and biological evaluation of novel 4-phenoxyquinoline derivatives containing 3-oxo-3,4-dihydroquinoxaline moiety as c-Met kinase inhibitors(2017)32 cited
• Up-regulated expression of a prostate cancer-related gene,NSBP1, in prostate cancer cells(2004)
• Down-regulation of kallikrein in prostate cancer(2008)
• → Abstract A33: Loss of Id4 initiates PIN-like lesions by maintaining stemness in mice prostate(2018)